PRMT inhibitor promotes SMN2 exon 7 inclusion and synergizes with nusinersen to rescue SMA mice
Abstract: Spinal muscular atrophy (SMA) is a leading genetic cause of infant mortality. The advent of approved treatments for this devastating condition has significantly changed SMA patients' life expectancy and quality of life. Nevertheless, these are not without limitations, and research efforts are underway to develop new approaches for improved and long‐lasting benefits for patients. Protein arginine methyltransferases (PRMTs) are emerging as druggable epigenetic targets, with several small‐molecule PRMT inhibitors already in clinical trials. From a screen of epigenetic molecules, we have identified MS023, a potent and selective type I PRMT inhibitor able to promote SMN2 exon 7 inclusion in preclinical SMA models. Treatment of SMA mice with MS023 results in amelioration of the disease phenotype, with strong synergistic amplification of the positive effect when delivered in combination with the antisense oligonucleotide nusinersen. Moreover, transcriptomic analysis revealed that MS023 treatment has minimal off‐target effects, and the added benefit is mainly due to targeting neuroinflammation. Our study warrants further clinical investigation of PRMT inhibition both as a stand‐alone and add‐on therapy for SMA.
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
PRMT inhibitor promotes SMN2 exon 7 inclusion and synergizes with nusinersen to rescue SMA mice ; day:19 ; month:09 ; year:2023 ; extent:21
EMBO molecular medicine / European Molecular Biology Organization ; (19.09.2023) (gesamt 21)
- Urheber
-
Kordala, Anna J.
Stoodley, Jessica
Ahlskog, Nina
Hanifi, Muhammad
Garcia Guerra, Antonio
Bhomra, Amarjit
Lim, Wooi Fang
Murray, Lyndsay M.
Talbot, Kevin
Hammond, Suzan M.
Wood, Matthew JA
Rinaldi, Carlo
- DOI
-
10.15252/emmm.202317683
- URN
-
urn:nbn:de:101:1-2023091915084604459814
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:48 MESZ
Datenpartner
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Kordala, Anna J.
- Stoodley, Jessica
- Ahlskog, Nina
- Hanifi, Muhammad
- Garcia Guerra, Antonio
- Bhomra, Amarjit
- Lim, Wooi Fang
- Murray, Lyndsay M.
- Talbot, Kevin
- Hammond, Suzan M.
- Wood, Matthew JA
- Rinaldi, Carlo
Ähnliche Objekte (12)
ELAV and nFNE determine neuronal transcript signatures through EXon-Activated Rescue
Cryptic exon inclusion is a molecular signature of LATE-NC in aging brains
Large-scale evaluation of the ability of RNA-binding proteins to activate exon inclusion
ExonSurfer: a web-tool to design primers at exon–exon junctions
Detection of internal exon deletion with exon Del
Author Correction: Large-scale evaluation of the ability of RNA-binding proteins to activate exon inclusion
Rescue of cardiomyopathy through U7sn RNA ‐mediated exon skipping in Mybpc3 ‐targeted knock‐in mice
CXCL14 Preferentially Synergizes With Homeostatic Chemokine Receptor Systems
E. H. Exon
Discovery of tissue-specific exons using comprehensive human exon microarrays
A compatible exon-exon junction database for the identification of exon skipping events using tandem mass spectrum data
POEM, A 3-dimensional exon taxonomy and patterns in untranslated exons
ELAV and nFNE determine neuronal transcript signatures through EXon-Activated Rescue
Cryptic exon inclusion is a molecular signature of LATE-NC in aging brains
Large-scale evaluation of the ability of RNA-binding proteins to activate exon inclusion
ExonSurfer: a web-tool to design primers at exon–exon junctions
Detection of internal exon deletion with exon Del
Author Correction: Large-scale evaluation of the ability of RNA-binding proteins to activate exon inclusion
Rescue of cardiomyopathy through U7sn RNA ‐mediated exon skipping in Mybpc3 ‐targeted knock‐in mice
CXCL14 Preferentially Synergizes With Homeostatic Chemokine Receptor Systems
E. H. Exon
Discovery of tissue-specific exons using comprehensive human exon microarrays
A compatible exon-exon junction database for the identification of exon skipping events using tandem mass spectrum data
POEM, A 3-dimensional exon taxonomy and patterns in untranslated exons
ELAV and nFNE determine neuronal transcript signatures through EXon-Activated Rescue
Cryptic exon inclusion is a molecular signature of LATE-NC in aging brains
Large-scale evaluation of the ability of RNA-binding proteins to activate exon inclusion
ExonSurfer: a web-tool to design primers at exon–exon junctions
Detection of internal exon deletion with exon Del
Author Correction: Large-scale evaluation of the ability of RNA-binding proteins to activate exon inclusion
Rescue of cardiomyopathy through U7sn RNA ‐mediated exon skipping in Mybpc3 ‐targeted knock‐in mice
CXCL14 Preferentially Synergizes With Homeostatic Chemokine Receptor Systems
E. H. Exon
Discovery of tissue-specific exons using comprehensive human exon microarrays
A compatible exon-exon junction database for the identification of exon skipping events using tandem mass spectrum data